Molecular Imaging Market: Increasing Application of Integrated PET-CT and PET-MR Devices to Drive Revenue Growth: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

  • Published: 2017-09-19
  • Report Code: REP-GB-724

An Incisive, In-depth Analysis on the Molecular Imaging Market

This study offers a comprehensive, 360 degree analysis on the Molecular Imaging market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Molecular Imaging market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Siemens AG and Hitachi Medical Corporation are among top 10 key players holding more than 55% revenue share in the global molecular imaging market

The top 10 key players contributed approximately 58% revenue share to the global molecular imaging market in 2016. The remaining players contributed approximately 42% revenue share to the global molecular imaging market in 2016. The top seven key players in the market contributed more than US$ 1,600 Mn, while other player’s contribution in the global molecular imaging market in 2016 was more than US$ 1,200 Mn. Around 52%, and 28% revenue is contributed by tier1 and tier 2 players respectively, while, 20% revenue is contributed by tier 3 players which are local/regional manufacturers.

With more than 11% CAGR, PET-MR segment by modality type is ahead of all other segments in terms of CAGR

SPECT segment dominated the global molecular imaging market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. PET-CT segment is expected to be the most lucrative among all modality, with attractiveness index of 2.2.  SPECT segment is expected to be the second largest market for molecular imaging market, with market share Index of 1.5. MR spectroscopy and software segments remain third-largest market and represents market share Index of 1.0.

Insufficient supply of molecular isotopes likely to hamper the growth of the North America molecular imaging market

The lesser availability and insufficient supply of molecular isotopes, which is required for molecular imaging devices, may restrain the growth of the global molecular imaging market in North America region over forecast period. For instance, technetium and molybdenum that support majority of SPECT procedures in cardiology, have been facing several disruptions in supply since last few years. The reactors from Canada which supply the molecular isotopes got permanently shut down in 2016 due to safety concerns.

Inadequate reimbursement policies expected to create a negative impact on the APEJ market for molecular imaging

Molecular imaging devices are expensive in APEJ region and therefore diagnosis cost is also unaffordable. Absence of health insurance and limited government support policies that cover diagnosis with high end technology devices, such as PET-CT and PET-MR in developing countries, such as India and China are adding to the woes in the present situation. The absence of social health insurance along with exclusionary provision of private health insurance schemes is a major factor limiting the growth of the molecular imaging market.

Product recalls and safety concerns are the major hindrances in the Western Europe molecular imaging market

Adverse events associated with the use of molecular imaging devices in evaluation, diagnosis, staging, restaging and follow up on lesions, diseases and organ dysfunctions, such as cancer, cardiovascular disease and brain dysfunction, may hamper the demand for devices and restrain the growth of the Western Europe market. For instance, in 2014, the GE Healthcare recalled CT and PET-CT devices to address safety concerns under FDA class-II regulation’s service manuals for a number of CT and PET CT scanners to update an incorrect torque value.

Japan market for molecular imaging likely to face obstacle due to short life of radiopharmaceuticals 

Imaging and diagnostic devices, such as SPECT and PET utilize radioisotope tracers in order to achieve better imaging capabilities and give more specific information about organ function and dysfunction. Fluoro-deoxy glucose (FDG) is incorporated with fluorine-18 and acts as the most commonly used tracer in PET imaging. The radiotracer has a half-life of just about two hours, which limits its utility in the diagnostic imaging industry. This has led to a decrease in the utilization of FDG, which has affected the PET based imaging market. Also, limited availability of the radiotracer FDG would also contribute towards the declining growth of the molecular imaging market in the region. 

In a recent publication titled “Molecular Imaging Market: Global Industry Analysis (2012 –2016) and Opportunity Assessment (2017 – 2027),” we have considered the weighted average pricing for different molecular imagingdevices. This has been done on the basis of information gathered from reliable secondarysources validated through marketplace discussions and private company databases. We have also observed that pricing values of molecular imaging devices have been counter validated with market experts through primary research along with regional variations in price levels. It is very necessary to note that this pricing analysis does not include margins analysis from the manufacturers end. Currency fluctuations have not been taken into account and the analysis is static in nature. It also rules out impact of extreme events in specific countries. Weighted averaging of high-end and low-end pricing has been done to rule out effect of extreme values and brand weightages. A demand-supply gap analysis has been performed involving both marketplace discussion and desk research to determine pricing premiums.

Report Structure

This report begins with the market definition, followed by definitions of the different molecular imaging devices. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors that are influencing the growth of the global molecular imaging market and key regulations for medical devices. Also, the pricing analysis of different products in the segment is mentioned for upcoming molecular imaging products. The report analyses the market on the basis of application and presents forecast by value for the next 10 years. The global molecular imaging market segments such as modality type, application, end-user and region, have been analysed on Basis Point Share (BPS) to understand the individual segment’s respective contributions to market growth. This detailed level of information is important for identifying various key trends in the global molecular imaging market.

At the end of the report, list of key players have been provided who are engaged in the market for global molecular imaging. This section is preferably designed to provide clients with an aim and detailed comparative assessment of key providers specific to the market segment in the global molecular imaging market and the potential players. In addition, this section includes company details, company overview, key developments and market strategies of the profiled key player active in the global molecular imaging market. Detailed profiles of molecular imaging devices manufacturers are also included in the scope of the report to evaluate their strategies in a bid to sustain in this competitive market.

Global Molecular Imaging Market: Segmentation

Modality Type

End User

Application

Region

  • PET

  • PET-CT

  • PET-MR

  • SPECT

  • MR Spectroscopy

  • Molecular Ultrasound Imaging

  • Software

    • On Premise Solutions

    • Cloud Based Solutions

  • Hospitals

    • 500+ Beds

    • 200-499 Beds

    • Less than 200 Beds

  • Ambulatory Surgical Centers

  • Diagnostic Imaging Centers

  • Cardiology

  • Oncology

  • Gastrointestinal Disorders

  • Neurology Disorders

  • Others

  • North America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • Latin America

  • MEA

Research Methodology

Macro-economic indicators such as molecular imaging market outlook, gross domestic product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers, while top-down approach has been used to counter-validate the reached numbers for molecular imaging Market numbers. The analysts of Future Market Insights have performed systematic exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Our analysts have developed questionnaires for each node in the value chain to extract the required market information through primary research interviews. While conducting interviews we have used distinguished essential resources. Data is validated by triangulation method, wherein secondary, primary and Future Market Insight’s analysis have contributed to the final data.

Molecular Imaging Market Reports - Table of Contents

Molecular Imaging Market Reports - List of Tables

Table 01: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 03: North America Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 04: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 05: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 06: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 07: Latin America Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 08: Latin America Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 09: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 10: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 11: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 12: Western Europe Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 13: Western Europe Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 14: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 15: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 16: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 17: Eastern Europe Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 18: Eastern Europe Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 19: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 20: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 21: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 22: APEJ Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 23: APEJ Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 24: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 25: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 26: Japan Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 27: Japan Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 28: Japan Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 29: Japan Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 30: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 31: MEA Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 32: MEA Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 33: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 34: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 35: Global Molecular Imaging Market Size (US$ Mn) Forecast By Region, 2012–2017

Table 36: Global Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 37: Global Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type

Table 38: Global Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application

Table 39: Global Molecular Imaging Market Size (US$ Mn) Forecast By End User, 2012–2017

Molecular Imaging Market Reports - List of Figures

Figure 01: North America Molecular Imaging Market Size Analysis, 2012–2016

Figure 02: North America Molecular Imaging Market Forecast, 2017–2027

Figure 03: U.S. Molecular Imaging Market Size Analysis, 2012–2016

Figure 04: U.S. Molecular Imaging Market Forecast, 2017–2027

Figure 05: Canada Molecular Imaging Market Size Analysis, 2012–2016

Figure 06: Canada Molecular Imaging Market Forecast, 2017–2027

Figure 07: North America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 08: North America PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 09: North America PET Molecular Imaging Market Forecast, 2017–2027

Figure 10: North America PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 11: North America PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 12: North America PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 13: North America PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 14: North America SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 15: North America SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 16: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 17: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 18: North America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 19: North America  Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 20: North America Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 21: North America Molecular Imaging Software Market Forecast, 2017–2027

Figure 22: North America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 23: North America Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 24: North America Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 25: North America Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 26: North America Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 27: North America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 28: North America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 29: North America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 30: North America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 31: North America Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 32: North America Other Molecular Imaging Market Forecast, 2017–2027

Figure 33: North America Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 34: North America Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 35: North America Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 36: North America Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 37: North America Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 38: North America Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 39: North America Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 40: North America Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 41: Latin America Molecular Imaging Market Size Analysis, 2012–2016

Figure 42: Latin America Molecular Imaging Market Forecast, 2017–2027

Figure 43: Brazil Molecular Imaging Market Size Analysis, 2012–2016

Figure 44: Brazil Molecular Imaging Market Forecast, 2017–2027

Figure 45: Mexico Molecular Imaging Market Size Analysis, 2012–2016

Figure 46: Mexico Molecular Imaging Market Forecast, 2017–2027

Figure 47: Rest of Latin America Molecular Imaging Market Size Analysis, 2012–2016

Figure 48: Rest of Latin America Molecular Imaging Market Forecast, 2017–2027

Figure 49: Latin America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 50: Latin America PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 51: Latin America PET Molecular Imaging Market Forecast, 2017–2027

Figure 52: Latin America PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 53: Latin America PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 54: Latin America PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 55: Latin America PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 56: Latin America SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 57: Latin America SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 58: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 59: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 60: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 61: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 62: Latin America Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 63: Latin America Molecular Imaging Software Market Forecast, 2017–2027

Figure 64: Latin America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 65: Latin America Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 66: Latin America Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 67: Latin America Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 68: Latin America Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 69:  Latin America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 70: Latin America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 71: Latin America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 72: Latin America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 73: Latin America Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 74: Latin America Other Molecular Imaging Market Forecast, 2017–2027

Figure 75: Latin America Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 76: Latin America Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 77: Latin America Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 78: Latin America Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 79: Latin America Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 80: Latin America Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 81: Latin America Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 82: Latin America Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 83: Western Europe Molecular Imaging Market Size Analysis, 2012–2016

Figure 84: Western Europe Molecular Imaging Market Forecast, 2017–2027

Figure 85: Germany Molecular Imaging Market Size Analysis, 2012–2016

Figure 86: Germany Molecular Imaging Market Forecast, 2017–2027

Figure 87: Italy Molecular Imaging Market Size Analysis, 2012–2016

Figure 88: Italy Molecular Imaging Market Forecast, 2017–2027

Figure 89: France Molecular Imaging Market Size Analysis, 2012–2016

Figure 90: France Molecular Imaging Market Forecast, 2017–2027

Figure 91: Spain Molecular Imaging Market Size Analysis, 2012–2016

Figure 92: Spain Molecular Imaging Market Forecast, 2017–2027

Figure 93: U.K. Molecular Imaging Market Size Analysis, 2012–2016

Figure 94: U.K. Molecular Imaging Market Forecast, 2017–2027

Figure 95: BENELUX Molecular Imaging Market Size Analysis, 2012–2016

Figure 96: BENELUX Molecular Imaging Market Forecast, 2017–2027

Figure 97: Rest of Western Europe Molecular Imaging Market Size Analysis, 2012–2016

Figure 98: Rest of Western Europe Molecular Imaging Market Forecast, 2017–2027

Figure 99: Western Europe Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 100: Western Europe PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 101: Western Europe PET Molecular Imaging Market Forecast, 2017–2027

Figure 102: Western Europe PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 103: Western Europe PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 104: Western Europe PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 105: Western Europe PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 106: Western Europe SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 107: Western Europe SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 108: Western Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 109: Western Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 110: Western Europe Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 111: Western Europe Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 112: Western Europe Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 113: Western Europe Molecular Imaging Software Market Forecast, 2017–2027

Figure 114: Western Europe Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 115: Western Europe Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 116: Western Europe Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 117: Western Europe Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 118: Western Europe Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 119: Western Europe Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 120: Western Europe Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 121: Western Europe Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 122: Western Europe Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 123: Western Europe Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 124: Western Europe Other Molecular Imaging Market Forecast, 2017–2027

Figure 125: Western Europe Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 126: Western Europe Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 127: Western Europe Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 128: Western Europe Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 129: Western Europe Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 130: Western Europe Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 131: Western Europe Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 132: Western Europe Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 133: Eastern Europe Molecular Imaging Market Size Analysis, 2012–2016

Figure 134: Eastern Europe Molecular Imaging Market Forecast, 2017–2027

Figure 135: Russia Molecular Imaging Market Size Analysis, 2012–2016

Figure 136: Russia Molecular Imaging Market Forecast, 2017–2027

Figure 137: Poland Molecular Imaging Market Size Analysis, 2012–2016

Figure 138: Poland Molecular Imaging Market Forecast, 2017–2027

Figure 139: Rest of Eastern Europe Molecular Imaging Market Size Analysis, 2012–2016

Figure 140: Rest of Eastern Europe Molecular Imaging Market Forecast, 2017–2027

Figure 141: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 142: Eastern Europe PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 143: Eastern Europe PET Molecular Imaging Market Forecast, 2017–2027

Figure 144: Eastern Europe PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 145: Eastern Europe PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 146: Eastern Europe PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 147: Eastern Europe PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 148: Eastern Europe SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 149: Eastern Europe SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 150: Eastern Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 151: Eastern Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 152: Eastern Europe Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 153: Eastern Europe Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 154: Eastern Europe Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 155: Eastern Europe Molecular Imaging Software Market Forecast, 2017–2027

Figure 156: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 157: Eastern Europe Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 158: Eastern Europe Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 159: Eastern Europe Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 160: Eastern Europe Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 161: Eastern Europe Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 162: Eastern Europe Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 163: Eastern Europe Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 164: Eastern Europe Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 165: Eastern Europe Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 166: Eastern Europe Other Molecular Imaging Market Forecast, 2017–2027

Figure 167: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 168: Eastern Europe Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 169: Eastern Europe Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 170: Eastern Europe Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 171: Eastern Europe Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 172: Eastern Europe Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 173: Eastern Europe Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 174: Eastern Europe Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 175: APEJ Molecular Imaging Market Size Analysis, 2012–2016

Figure 176: APEJ Molecular Imaging Market Forecast, 2017–2027

Figure 177: China Molecular Imaging Market Size Analysis, 2012–2016

Figure 178: China Molecular Imaging Market Forecast, 2017–2027

Figure 179: India Molecular Imaging Market Size Analysis, 2012–2016

Figure 180: India Molecular Imaging Market Forecast, 2017–2027

Figure 181: Australia and New Zealand Molecular Imaging Market Size Analysis, 2012–2016

Figure 182: Australia and New Zealand Molecular Imaging Market Forecast, 2017–2027

Figure 183: ASEAN Molecular Imaging Market Size Analysis, 2012–2016

Figure 184: ASEAN Molecular Imaging Market Forecast, 2017–2027

Figure 185: Rest of APEJ Molecular Imaging Market Size Analysis, 2012–2016

Figure 186: Rest of APEJ Molecular Imaging Market Forecast, 2017–2027

Figure 187: APEJ Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 188: APEJ PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 189: APEJ PET Molecular Imaging Market Forecast, 2017–2027

Figure 190: APEJ PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 191: APEJ PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 192: APEJ PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 193: APEJ PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 194: APEJ SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 195: APEJ SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 196: APEJ Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 197: APEJ Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 198: APEJ Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 199: APEJ Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 200: APEJ Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 201: APEJ Molecular Imaging Software Market Forecast, 2017–2027

Figure 202: APEJ Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 203: APEJ Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 204: APEJ Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 205: APEJ Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 206: APEJ Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 207: APEJ Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 208: APEJ Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 209: APEJ Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 210: APEJ Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 211: APEJ Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 212: APEJ Other Molecular Imaging Market Forecast, 2017–2027

Figure 213: APEJ Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 214: APEJ Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 215: APEJ Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 216: APEJ Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 217: APEJ Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 218: APEJ Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 219: APEJ Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 220: APEJ Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 221: Japan Molecular Imaging Market Size Analysis, 2012–2016

Figure 222: Japan Molecular Imaging Market Forecast, 2017–2027

Figure 223: Japan PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 224: Japan PET Molecular Imaging Market Forecast, 2017–2027

Figure 225: Japan PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 226: Japan PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 227: Japan PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 228: Japan PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 229: Japan SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 230: Japan SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 231: Japan Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 232: Japan Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 233: Japan Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 234: Japan Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 235: Japan Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 236: Japan Molecular Imaging Software Market Forecast, 2017–2027

Figure 237: Japan Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 238: Japan Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 239: Japan Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 240: Japan Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 241: Japan Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 242: Japan Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 243: Japan Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 244: Japan Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 245: Japan Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 246: Japan Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 247: Japan Other Molecular Imaging Market Forecast, 2017–2027

Figure 248: Japan Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 249: Japan Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 250: Japan Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 251: Japan Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 252: Japan Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 253: Japan Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 254: Japan Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 255: Japan Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 256: MEA Molecular Imaging Market Size Analysis, 2012–2016

Figure 257: MEA Molecular Imaging Market Forecast, 2017–2027

Figure 258: GCC Countries Molecular Imaging Market Size Analysis, 2012–2016

Figure 259: GCC Countries Molecular Imaging Market Forecast, 2017–2027

Figure 260: South Africa Molecular Imaging Market Size Analysis, 2012–2016

Figure 261: South Africa Molecular Imaging Market Forecast, 2017–2027

Figure 262: Rest of MEA Molecular Imaging Market Size Analysis, 2012–2016

Figure 263: Rest of MEA Molecular Imaging Market Forecast, 2017–2027

Figure 264: MEA Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027 

Figure 265: PET Molecular Imaging Market Size Analysis, 2012–2016

Figure 266: PET Molecular Imaging Market Forecast, 2017–2027

Figure 267: PET-CT Molecular Imaging Market Size Analysis, 2012–2016

Figure 268: PET-CT Molecular Imaging Market Forecast, 2017–2027

Figure 269: PET-MR Molecular Imaging Market Size Analysis, 2012–2016

Figure 270: PET-MR Molecular Imaging Market Forecast, 2017–2027

Figure 271: SPECT Molecular Imaging Market Size Analysis, 2012–2016

Figure 272: SPECT Molecular Imaging Market Forecast, 2017–2027

Figure 273: Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016

Figure 274: Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027

Figure 275: Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016

Figure 276: Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027

Figure 277: MEA Molecular Imaging Software Market Size Analysis, 2012–2016

Figure 278: MEA Molecular Imaging Software Market Forecast, 2017–2027

Figure 279: MEA Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027 

Figure 280: MEA Cardiology Molecular Imaging Market Size Analysis, 2012–2016

Figure 281: MEA Cardiology Molecular Imaging Market Forecast, 2017–2027

Figure 282: MEA Oncology Molecular Imaging Market Size Analysis, 2012–2016

Figure 283: MEA Oncology Molecular Imaging Market Forecast, 2017–2027

Figure 284: MEA Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 285: MEA Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 286: MEA Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016

Figure 287: MEA Neurology Disorders Molecular Imaging Market Forecast, 2017–2027

Figure 288: MEA Other Molecular Imaging Market Size Analysis, 2012–2016

Figure 289: MEA Other Molecular Imaging Market Forecast, 2017–2027

Figure 290: MEA Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 291: MEA Hospital Molecular Imaging Market Size Analysis, 2012–2016

Figure 292: MEA Hospital Molecular Imaging Market Forecast, 2017–2027

Figure 293: MEA Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 294: MEA Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027

Figure 295: MEA Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016

Figure 296: MEA Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027

Figure 297: MEA Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 298: Global Molecular Imaging Market Attractiveness Analysis By Region, 2017–2027 

Figure 299: Global Molecular Imaging Market Attractiveness Analysis By Modality Type, 2017–2027 

Figure 300: Global Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027 

Figure 301: Global Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027 

Figure 302: Global Molecular Imaging Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 303: Global Molecular Imaging Market Absolute $ Opportunity (US$ Mn), 2012–2016

Figure 304: Global Molecular Imaging Market Absolute $ Opportunity (US$ Mn), 2016–2027

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology